ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

Japan · Delayed Price · Currency is JPY

2,930.00

+24.00 (0.83%)

May 29, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Other		325.00M	226.00M	298.00M	5.89B		4.77B
Other Growth		43.81%	-24.16%	-94.94%	-		-4.74%
Pharmaceuticals Business		56.66B	56.02B	53.58B	50.79B		47.85B
Pharmaceuticals Business Growth		1.14%	4.55%	5.49%	-		14.59%
Unallocated Adjustment		-88.00M	-64.00M	-77.00M	-73.00M		-76.00M
Animal Health Business		7.25B	6.66B	6.66B	-		-
Animal Health Business Growth		8.73%	0.06%	-	-		-
Total		64.14B	62.84B	60.46B	56.61B		52.54B
Total Growth		2.06%	3.94%	6.80%	-		12.50%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Japan		64.14B	62.84B	60.46B	56.61B		52.54B
Japan Growth		2.06%	3.94%	6.81%	-		12.50%
Total		64.14B	62.84B	60.46B	56.61B		52.54B
Total Growth		2.06%	3.94%	6.81%	-		12.50%

Source: S&P Global Market Intelligence.